Literature DB >> 25523818

Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.

Masaru Ishida1,2, Shuji Mikami3, Toshiaki Shinojima1, Takeo Kosaka1, Ryuichi Mizuno1, Eiji Kikuchi1, Akira Miyajima1, Yasunori Okada4, Mototsugu Oya1.   

Abstract

Although exposure to environmental pollutants is one of the risk factors for renal cell carcinoma (RCC), its relationship with carcinogenesis and the progression of RCC remains unknown. The present study was designed to elucidate the role of the aryl hydrocarbon receptor (AhR), a major mediator of carcinogenesis caused by environmental pollutants, in the progression of RCC. The expression of AhR was investigated in 120 patients with RCC using immunohistochemistry, and its relationship with clinicopathological parameters and prognoses was statistically analyzed. RCC cell lines were exposed to indirubin or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), AhR ligands, to activate the AhR pathway, or were transfected with small interfering RNA (siRNA) for AhR. The expression of the AhR target genes CYP1A1 and CYP1B1, matrix metalloproteinases (MMPs), and invasion through Matrigel(TM) were then examined. AhR was predominantly expressed in the nuclei of high-grade clear cell RCC (ccRCC) and tumor-infiltrating lymphocytes (TILs), and its expression levels in cancer cells and TILs correlated with the pathological tumor stage and histological grade. A multivariate Cox analysis revealed that the strong expression of AhR in cancer cells was a significant and independent predictor of disease-specific survival. AhR ligands up-regulated the expression of AhR and CYPs and promoted invasion by up-regulating MMPs. Furthermore, siRNA for AhR down-regulated CYPs, and inhibited cancer cell invasion together with the down-regulation of MMPs. These results suggest that AhR regulates the invasion of ccRCC and may be involved in tumor immunity. Therefore, inhibiting the activation of AhR may represent a potentially attractive therapeutic target for ccRCC patients.
© 2014 UICC.

Entities:  

Keywords:  aryl hydrocarbon receptor; cigarette smoke; invasion; prognosis; renal cell carcinoma; tumor-infiltrating lymphocyte

Mesh:

Substances:

Year:  2015        PMID: 25523818     DOI: 10.1002/ijc.29398

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma.

Authors:  Anna Bianchi-Smiraglia; Archis Bagati; Emily E Fink; Hayley C Affronti; Brittany C Lipchick; Sudha Moparthy; Mark D Long; Spencer R Rosario; Shivana M Lightman; Kalyana Moparthy; David W Wolff; Dong Hyun Yun; Zhannan Han; Anthony Polechetti; Matthew V Roll; Ilya I Gitlin; Katerina I Leonova; Aryn M Rowsam; Eugene S Kandel; Andrei V Gudkov; P Leif Bergsagel; Kelvin P Lee; Dominic J Smiraglia; Mikhail A Nikiforov
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

2.  The Aryl Hydrocarbon Receptor (AhR) as a Drug Target for Cancer Chemotherapy.

Authors:  Stephen Safe; Yating Cheng; Un-Ho Jin
Journal:  Curr Opin Toxicol       Date:  2017-02-01

3.  Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs.

Authors:  Hatice U Osmanbeyoglu; Eneda Toska; Carmen Chan; José Baselga; Christina S Leslie
Journal:  Nat Commun       Date:  2017-01-31       Impact factor: 14.919

4.  Compendium of TCDD-mediated transcriptomic response datasets in mammalian model systems.

Authors:  Stephenie D Prokopec; Kathleen E Houlahan; Ren X Sun; John D Watson; Cindy Q Yao; Jamie Lee; Christine P'ng; Renee Pang; Alexander H Wu; Lauren C Chong; Ashley B Smith; Nicholas J Harding; Ivy D Moffat; Jere Lindén; Sanna Lensu; Allan B Okey; Raimo Pohjanvirta; Paul C Boutros
Journal:  BMC Genomics       Date:  2017-01-13       Impact factor: 3.969

Review 5.  New Treatments in Renal Cancer: The AhR Ligands.

Authors:  Boris Itkin; Alastair Breen; Lyudmila Turyanska; Eduardo Omar Sandes; Tracey D Bradshaw; Andrea Irene Loaiza-Perez
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

6.  Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation.

Authors:  Chih-Cheng Chang; Kuo-How Huang; Sung-Po Hsu; Yuan-Chii G Lee; Yuh-Mou Sue; Shu-Hui Juan
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

Review 7.  Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma.

Authors:  Hui Zhao; Lin Chen; Tian Yang; Ya-Long Feng; Nosratola D Vaziri; Bao-Li Liu; Qing-Quan Liu; Yan Guo; Ying-Yong Zhao
Journal:  J Transl Med       Date:  2019-09-05       Impact factor: 5.531

8.  A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.

Authors:  Zhuomao Mo; Pan Li; Zhirui Cao; Shijun Zhang
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

9.  Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial-mesenchymal transition in non-small cell lung cancer cells.

Authors:  Ching-Hao Li; Chen-Wei Liu; Chi-Hao Tsai; Yi-Jen Peng; Yu-Hsuan Yang; Po-Lin Liao; Chen-Chen Lee; Yu-Wen Cheng; Jaw-Jou Kang
Journal:  Arch Toxicol       Date:  2016-10-17       Impact factor: 5.153

10.  Occupational Pesticide Use and Risk of Renal Cell Carcinoma in the Agricultural Health Study.

Authors:  Gabriella Andreotti; Laura E Beane Freeman; Joseph J Shearer; Catherine C Lerro; Stella Koutros; Christine G Parks; Aaron Blair; Charles F Lynch; Jay H Lubin; Dale P Sandler; Jonathan N Hofmann
Journal:  Environ Health Perspect       Date:  2020-06-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.